TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

CTGCT CENTRE FOR THE TECHNOLOGIES OF GENE AND CELL THERAPY

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: MistaEscritório: US

Snapshot rápido

CTGCT CENTRE FOR THE TECHNOLOGIES OF GENE AND CELL THERAPY

ST13

US500000079404288

Classe

1, 5, 9, 10, 16, 25, 41, 42

Pedido

79404288

Registro

8007020

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

30

Atualização mais recente

29/05/2026

Classificação

Registrada

Tipo de marca

Mista

Classes Nice

1, 5, 9, 10, 16, 25, 41, 42

Data de depósito

30/04/2024

Data de registro

04/11/2025

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

04/11/2025

Última transação

29/05/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

3

Tipo de titular

99

Localização do titular

SI

Examinador

LEE, YATSYE ISADORA

Unidade examinadora

L70

Localização atual

FILE REPOSITORY (FRANCONIA)

Descrição da marca

The mark consists of two adjacent, slightly offset quadrilaterals outlined in blue, displaying the letters "CTGCT" in blue upon a white background, all of which appears above the wording "CENTRE FOR THE TECHNOLOGIES OF GENE AND CELL THERAPY" in blue.

Titulares e representantes

Titulares

Kemijski institut

Representantes

Jennifer Fraser Dykema Gossett PLLC

Classificação técnica

Classes Nice

Classe 1Classe 5Classe 9Classe 10Classe 16Classe 25Classe 41Classe 42

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 1

Chemicals for use in science; Chemical substances for analyses in laboratories, other than for medical or veterinary purposes; chemical materials, namely assays, reagents, and nucleic acids for use in gene and cell therapy research; Chemical preparations for scientific purposes; natural fertilisers; chemical products used in gene and cell therapy technologies, namely viral vectors, plasmids, and lipid nanoparticles for gene delivery; active chemical ingredients used in the manufacture of medicines for diseases and cancer

Classe 5

Pharmaceuticals and medical preparations for the treatment of genetic diseases, neurodevelopmental diseases and cancers; Diagnostic preparations for medical purposes; cells for medical use; pharmaceutical and medical preparations used in gene and cell therapy technologies; pharmaceutical compounds, preparations, and medicines used in the treatment of genetic diseases, neurodevelopmental diseases, and cancers; pharmaceutical compounds, preparations, and medicines used in the treatment of genetic diseases and cancer

Classe 9

Scientific, research, teaching and detecting apparatus and instruments, namely, microscopes, confocal laser microscopes, flow cytometers, bioreactors for cell culturing, cell sorters, and analytical systems composed of microscopes, spectrophotometers, luminometers, spectrofluorimeters, and computer hardware for analyzing cells; downloadable computer software for analyzing biological data, designing gene and cell therapies, and managing laboratory processes in the field of gene and cell therapy; scientific apparatus and instruments, namely, microscopes, confocal laser microscopes, flow cytometers, and bioreactors for cell culturing, and downloadable computer software for analyzing cell populations, designing viral vectors, and optimizing bioreactor processes used in gene and cell therapy technologies; scientific apparatus and instruments, namely, high-throughput confocal microscopes for kinetics measurements and in vivo imaging systems composed of micro CT, magnetic resonance imaging apparatus, not for medical purposes, for live animal imaging in gene and cell therapy research, and downloadable computer software for analyzing genetic sequences and modeling drug responses used in the treatment of diseases and cancer; Prerecorded USB flash drives featuring educational content on gene and cell therapy technologies and their applications in treating diseases and cancer

Classe 10

Surgical and medical apparatus and instruments for use in gene therapy and cell therapy; surgical and medical apparatus and instruments used during medical and surgical procedures; medical apparatuses and instruments, namely, bioreactors, cell sorters, flow cytometers, and analytical systems composed of medical imaging apparatuses all of which provide cell and particle analysis, detection, or counting for medical, medical diagnostic, and therapeutic uses in the field of gene and cell therapy technologies; medical devices used in the treatment of genetic diseases and cancers

Classe 16

Printed matter, namely, printed brochures, reports, and educational materials in the field of gene and cell therapy, advanced therapy medicinal products (ATMPs), and translational medicine; bookbinding tape; printed photographs; stationery and office requisites, namely, printed notepads; printed notebooks; printed journals related to gene and cell therapy technology; printed informational flyers related to the treatment of diseases and cancer

Classe 25

Clothing, namely, lab coats, pants, shirts, t-shirts and headwear

Classe 41

Education, namely, conferences, workshops, seminars, and online courses in the field of gene and cell therapy, advanced therapy medicinal products (ATMPs), and translational medicine and distribution of course material in connection therewith; publication of texts, providing online non-downloadable news articles in the field of gene and cell therapy, ATMPs, and translational medicine, and writing of texts, namely, writing of articles for professional journals other than for advertising or publicity; audio, video, and multimedia production, as well as photography; educational and teaching services, namely, workshops, seminars, conferences, online courses, and hands-on training in the field of gene and cell therapy, ATMPs, and translational medicine; organizing conferences, exhibitions, and competitions in the field of gene and cell therapy, ATMPs, and translational medicine; education, namely, conferences, workshops, seminars, and online courses in the field of gene and cell therapy technology; education, namely, workshops, seminars, and training programs in the treatment of diseases and cancer

Classe 42

Scientific and technological services, namely, research and design in the fields of treatments for genetic diseases, neurodevelopmental diseases and cancers, and gene and cell therapy technology; industrial analysis, industrial research and industrial design services in the fields of treatments for genetic diseases, neurodevelopmental diseases and cancers, and gene and cell therapy technology; quality control and authentication services in the field of gene and cell therapy products; design and development of computer hardware and software; scientific laboratory services; biological and medical research laboratory services; laboratory services, namely, rental of laboratory apparatus and instruments; Research laboratory analysis services in the field of gene therapy, cell therapy, and synthetic biology; biological research, clinical research in the field of gene therapy and cell therapy for genetic diseases, neurodevelopmental diseases and difficult-to-treat cancers, and medical research; design and development of medical technology; development of new technologies for others in the field of gene and cell therapies; design and development of gene and cell therapy technology; scientific research for medical purposes in the field of diseases and cancer

Publicações

Histórico de despachos e eventos da marca no USPTO.

30 publicações encontradas

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

28/05/2026

FICS

FINAL DISPOSITION NOTICE SENT TO IB

12/05/2026

FIMP

FINAL DISPOSITION PROCESSED

12/05/2026

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

26/02/2026

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

11/02/2026

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

11/02/2026

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

04/02/2026

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

04/11/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

04/11/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

16/09/2025

PUBO

PUBLISHED FOR OPPOSITION

16/09/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

10/09/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

14/08/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

14/08/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

13/08/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

13/08/2025

RFNP

REFUSAL PROCESSED BY IB

19/07/2025

CNRT

NON-FINAL ACTION WRITTEN

23/06/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

13/05/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

13/05/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

13/05/2025

RFNT

REFUSAL PROCESSED BY IB

21/12/2024

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

02/12/2024

RFRR

REFUSAL PROCESSED BY MPU

02/12/2024

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

16/11/2024

CNRT

NON-FINAL ACTION WRITTEN

15/11/2024

DOCK

ASSIGNED TO EXAMINER

14/11/2024

MAFR

APPLICATION FILING RECEIPT MAILED

16/09/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

16/09/2024

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

12/09/2024

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace CTGCT CENTRE FOR THE TECHNOLOGIES OF GENE AND CELL THERAPY ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.